This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 May 13;82(19):1670-1.

doi: 10.1212/WNL.0000000000000421. Epub 2014 Apr 11.

Bevacizumab for glioblastoma: what can we learn from patterns of progression?

Patrick Y Wen¹, Larry Junck

Affiliations

Affiliation

¹ From the Center for Neuro-Oncology (P.Y.W.), Dana Farber/Brigham and Women's Cancer Center, and Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Boston, MA; and the Department of Neurology and Comprehensive Cancer Center (L.J.), University of Michigan, Ann Arbor.

PMID: 24727316
DOI: 10.1212/WNL.0000000000000421

Editorial

Bevacizumab for glioblastoma: what can we learn from patterns of progression?

Patrick Y Wen et al. Neurology. 2014.

. 2014 May 13;82(19):1670-1.

doi: 10.1212/WNL.0000000000000421. Epub 2014 Apr 11.

Authors

Patrick Y Wen¹, Larry Junck

Affiliation

¹ From the Center for Neuro-Oncology (P.Y.W.), Dana Farber/Brigham and Women's Cancer Center, and Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Boston, MA; and the Department of Neurology and Comprehensive Cancer Center (L.J.), University of Michigan, Ann Arbor.

PMID: 24727316
DOI: 10.1212/WNL.0000000000000421

No abstract available

PubMed Disclaimer

Comment on

Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma.
Nowosielski M, Wiestler B, Goebel G, Hutterer M, Schlemmer HP, Stockhammer G, Wick W, Bendszus M, Radbruch A. Nowosielski M, et al. Neurology. 2014 May 13;82(19):1684-92. doi: 10.1212/WNL.0000000000000402. Epub 2014 Apr 11. Neurology. 2014. PMID: 24727314

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations